BL
HZNP

Balentine LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Balentine LLC’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,758
Closed -$203K – 620
2023
Q3 		$203K Buy
+1,758
New +$189K 0.01% 459
2022
Q2 		– Sell
-2,197
Closed -$231K – 723
2022
Q1 		$231K Buy
+2,197
New +$214K 0.01% 507

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balentine LLC's HZNP Position: Q4 2023 in Review

Balentine LLC sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,758 shares — an estimated $203K sold.

Balentine LLC first reported a position in HZNP in Q1 2022 and held it in 2 quarters. The position peaked at $231K in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Balentine LLC reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Balentine LLC sold 1,758 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $203K.
  • Balentine LLC first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022 and held it in 2 quarters.
  • Balentine LLC's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $231K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Balentine LLC's 13F filing for Q4 2023, filed 9 Feb 2024.